Fukushima, Japan

Ayako Saito


Average Co-Inventor Count = 4.8

ph-index = 1

Forward Citations = 34(Granted Patents)


Location History:

  • Fukushima, JP (2000)
  • Ohwashi Tsukuba, Ibaraki JP (2011)

Company Filing History:

goldMedal1 out of 314 
 
Taisho Pharmaceutical Co., Ltd.
 patents
silverMedal2 out of 832,680 
Other
 patents
where one patent can have more than one assignee

Years Active: 2000-2011

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Ayako Saito: Innovator in Trehalose Transport and Mucosal Immunity

Introduction

Ayako Saito is a prominent inventor based in Fukushima, Japan. She has made significant contributions to the fields of cell biology and immunology, holding 2 patents that showcase her innovative research.

Latest Patents

One of her latest patents is a method of increasing cell permeability to trehalose by recombinantly producing a trehalose transporter. This invention involves the identification of a trehalose transporter gene, leading to the introduction of trehalose into cells. The gene, designated as Tret1, encodes a 504 amino acid protein with 12 trans-membrane structures. Tret1 expression is induced by desiccation stress and is predominantly found in the fat body. Functional expression of TRET1 in oocytes demonstrated that the transport activity is specific for trehalose and is independent of extracellular pH and electrochemical membrane potential. The transport direction of TRET1 is reversible, depending on the concentration gradient of trehalose, with extraordinarily high values for apparent Km and Vmax. These findings indicate that TRET1 is a facilitated, high-capacity trehalose-specific transporter, which is widespread in insects. Furthermore, TRET1 has conferred trehalose permeability upon cells, including those of vertebrates.

Another significant patent by Saito is a method for inducing mucosal immunity. This method involves injecting plasmid DNAs or oligonucleotides containing a specific DNA sequence into mammalian mucosal cells. This process induces mucosal immunity and promotes the development of CD4 positive T cells capable of producing interleukin 10 and IFN-γ.

Career Highlights

Throughout her career, Ayako Saito has worked with notable companies, including Taisho Pharmaceutical Co., Ltd. Her research has significantly impacted the understanding of trehalose transport and mucosal immunity.

Collaborations

Saito has collaborated with esteemed colleagues, including Yukio Sato and Atsushi Irisawa, contributing to her innovative research and advancements in her field.

Conclusion

Ayako Saito's work in trehalose transport and mucosal immunity exemplifies her dedication to scientific innovation. Her patents reflect her commitment to advancing knowledge in cell biology and immunology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…